See today's BioWorld Science
To read the full story, subscribe or sign in.
Endocrine/metabolic

Adipopharma raises funding for phase I trials of PATAS for type 2 diabetes

Nov. 12, 2024
Adipopharma SAS has secured funding to begin phase I trials of PATAS, a compound with a novel mechanism for treating type 2 diabetes.
BioWorld Science Diabetes Endocrine/metabolic Peptide